Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Hepatology ; 24(6): 1361-5, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8938162

ABSTRACT

Members of the herpes virus family and hepatitis B virus (HBV) have been implicated as etiologic agents in non-A, non-B (NANB) fulminant hepatic failure (FHF), but the frequency of infection with these agents has not been established using appropriate controls. To examine this issue, we studied 50 NANB FHF patients and 104 liver transplant recipients from North America and Europe. Hepatic DNA was analyzed by polymerase chain reaction (PCR) for evidence of Epstein-Barr virus (EBV), cytomegalovirus (CMV), herpes simplex virus I (HSV I) and II (HSV II), varicella-zoster virus (VZV), and human herpes virus-6 (HHV-6) nucleic acid sequences. The prevalence of HBV was assessed in North American subjects only. HSV I, HSV II, VZV, and HHV-6 viral sequences were not observed in any samples. Three of 50 FHF (6%) and 14 of 104 control patients (13%) were positive for CMV DNA. Two of 50 FHF (4%) and 10 of 104 control patients (10%) had EBV DNA, and HBV DNA was observed in 3 of 10 North American FHF patients (30%) and 3 of 59 controls (5%) without serum markers for HBV infection. The finding of HBV DNA in the liver of seronegative controls from North America but not Europe suggests that occult hepatitis B sequences in patients with NANB FHF may simply reflect geographic differences. The majority of cryptogenic FHF cases cannot be attributed to infection with herpes viruses or HBV.


Subject(s)
DNA, Viral/analysis , Hepatic Encephalopathy/virology , Hepatitis B virus/isolation & purification , Hepatitis C/virology , Herpesviridae/isolation & purification , Liver/virology , Adolescent , Adult , Aged , Base Sequence , Child , Child, Preschool , Cytomegalovirus/isolation & purification , DNA Primers , Europe , Female , Hepatic Encephalopathy/pathology , Hepatitis C/pathology , Herpesvirus 1, Human/isolation & purification , Herpesvirus 2, Human/isolation & purification , Herpesvirus 3, Human/isolation & purification , Herpesvirus 4, Human/isolation & purification , Herpesvirus 6, Human/isolation & purification , Humans , Infant , Liver/pathology , Male , Middle Aged , North America , Polymerase Chain Reaction/methods , Retrospective Studies
3.
J Infect Dis ; 167(3): 562-6, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8440927

ABSTRACT

Monoclonal antibodies and ribonuclease protection were used to analyze antigenic and genomic diversity among 42 isolates of group A respiratory syncytial virus (RSV) from studies of nosocomial RSV carried out at the University of Rochester during the 1974-1975 and 1975-1976 RSV seasons. Three distinct subgroups or lineages and a total of 12 viral variants were present. Against this background of diversity, an outbreak was recognized that included 13 indistinguishable isolates occurring during a 2-week period. This outbreak accounted for 6 of the 8 infants with nosocomial infection. In contrast to the limited diversity of the nosocomial isolates, isolates from the 10 infants with community-acquired infection included 8 variants. Like those from community outbreaks of RSV, isolates of RSV from hospitalized patients are virologically heterogeneous. However, discrete outbreaks associated with transmission of a single strain can occur.


Subject(s)
Antigens, Viral/immunology , Cross Infection/microbiology , Disease Outbreaks , Respiratory Syncytial Viruses/classification , Respirovirus Infections/microbiology , Acute Disease , Child , Cross Infection/epidemiology , Cross Infection/transmission , Humans , Infant , New York/epidemiology , Occupational Diseases/epidemiology , Occupational Diseases/microbiology , Personnel, Hospital , RNA, Viral/analysis , Respiratory Syncytial Viruses/genetics , Respiratory Syncytial Viruses/immunology , Respirovirus Infections/epidemiology , Respirovirus Infections/transmission
4.
J Infect Dis ; 163(4): 858-61, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2010638

ABSTRACT

Antigenic analysis using monoclonal antibodies and genomic analysis using ribonuclease protection was done on 47 isolates of group A respiratory syncytial virus (RSV) recovered from children in St. Louis during four RSV seasons. Antigenic analysis identified four subgroups; of the three that included more than one member, those designated A/2 and A/2V had characteristic ribonuclease protection patterns. A third subgroup, A/4, exhibited more extensive genomic heterogeneity, but all isolates were distinguishable from those in subgroups A/2 and A/2V. Individual RSV epidemic seasons included isolates representing multiple subgroups of group A and multiple intrasubgroup variants, in addition to isolates from group B. Isolates that were indistinguishable by either antigenic or genomic analysis were present in more than one epidemic season. The subgroups may represent parallel evolutionary lineages, whose relevance to RSV immunity and pathogenesis requires further study.


Subject(s)
Antigens, Viral/analysis , Genetic Variation , RNA, Viral/analysis , Respiratory Syncytial Viruses/immunology , Respirovirus Infections/microbiology , Antibodies, Monoclonal/immunology , Antigenic Variation , Child , Humans , Respiratory Syncytial Viruses/genetics , Ribonucleases
6.
J Med Virol ; 29(1): 38-45, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2573686

ABSTRACT

The Oka vaccine strains of varicella-zoster virus (VZV) have a significantly different BgII DNA restriction pattern from that of American wild-type isolates of VZV. This difference consists primarily of an additional BgII site, which lies within the BamHI "D" fragment. In conjunction with a study of the efficacy of an experimental Merck/Oka VZV vaccine, the area of the genome from which the most marked restriction pattern alteration arises was studied more closely to determine if there are other significant differences between the Oka strains and American wild-type strains. BamHI "D" fragments from the DNA of the Oka parent strain (the progenitor of the vaccine strain), the RIT/Oka vaccine strain (a derivative of the Oka parent strain), the Merck/Oka vaccine strain, and the EF strain (an American wild type), were submitted to extensive endonuclease digestion studies to ascertain if additional unique restriction sites are present in the Oka parent or vaccine strains. The extra BgII restriction site characteristic of the Merck/Oka vaccine strain is also present in the DNA of the parent virus as well as its derivatives and was therefore not produced by the "attenuation" process. No other novel sites were found in the Oka parent or Oka-derived strains in this section of the genome. The Merck/Oka vaccine strain of VZV, despite its Japanese origin, is therefore quite similar to circulating American varicella-zoster virus strains. Varicella-zoster virus DNA, at least in the area of the BamHI D fragment, also appears to be remarkably stable from strain to strain.


Subject(s)
Herpesvirus 3, Human/genetics , Polymorphism, Restriction Fragment Length , Restriction Mapping , Blotting, Southern , Herpesvirus 3, Human/immunology , Species Specificity , Vaccines, Attenuated , Viral Vaccines
7.
J Clin Invest ; 83(6): 1894-902, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2723064

ABSTRACT

We have used the technique of ribonuclease protection to define genomic variation among circulating isolates of subgroup A respiratory syncytial (RS) virus. RNAs extracted from HEp-2 cells infected with strains to be analyzed were hybridized with a 32P-labeled RNA probe corresponding to the RS virus G glycoprotein (A2 strain). Areas of nonhomology were detected by cleavage with ribonuclease A. Using this technique, multiple distinct RNA cleavage patterns could be distinguished among viral isolates recovered from infants residing in the same metropolitan area and infected during the same epidemic season. Epidemiologically related isolates (from coinfected twins, from infants infected during a nosocomial outbreak at an extended care facility, and from institutionalized adults infected during an outbreak) yielded identical patterns. In two separate outbreaks, differences in cleavage patterns among certain isolates corresponded to epidemiologically significant differences among the individuals from whom the isolates were recovered. We conclude that substantial genomic heterogeneity exists among circulating isolates of subgroup A RS virus. Ribonuclease protection can be used as a molecular fingerprinting tool for expanded studies of the molecular epidemiology of this virus.


Subject(s)
Nucleotide Mapping , RNA Probes , RNA, Viral/isolation & purification , Respiratory Syncytial Viruses/genetics , Respirovirus Infections/epidemiology , Ribonucleases , Adult , Disease Outbreaks , Genetic Variation , Humans , Infant , Missouri , Nucleic Acid Denaturation , Nucleic Acid Hybridization , Nucleotide Mapping/methods , RNA, Viral/genetics , Respiratory Syncytial Viruses/growth & development , Respiratory Syncytial Viruses/isolation & purification , Respirovirus Infections/genetics , Respirovirus Infections/microbiology
8.
J Gen Virol ; 69 ( Pt 9): 2229-49, 1988 Sep.
Article in English | MEDLINE | ID: mdl-2842434

ABSTRACT

A persistent infection with varicella-zoster virus was established in the Mewo human melanoma cell line. This persistently infected cell line went through periodic crises of virus-induced cell killing and then recovery. Analyses of viral DNA derived from the persistently infected cultures revealed that novel viral nucleic acid rearrangements had been generated. These viral DNA sequences were derived from a specific region of the inverted repeat sequence of the genome flanking the short unique genome segment. The novel DNA was of various lengths, each generated by tandem duplication of an approximately 2760 base pair sub-sequence of the normal viral inverted repeat. These novel sequences were inserted into an otherwise apparently normal genome.


Subject(s)
DNA, Viral/genetics , Herpesvirus 3, Human/genetics , Antigens, Viral/analysis , Genes, Viral , Herpesvirus 3, Human/immunology , Humans , Multigene Family , Nucleic Acid Hybridization , Tumor Cells, Cultured
9.
J Med Virol ; 24(3): 329-41, 1988 Mar.
Article in English | MEDLINE | ID: mdl-2835429

ABSTRACT

Several clinical varicella-zoster virus isolates obtained during testing of a live varicella vaccine had DNA restriction fragment patterns resembling neither vaccine nor wild-type virus [Gelb et al., J Infect. Dis. 155, 633-640, 1987]. One explanation for these isolates was recombination in vivo. To determine if such recombination is likely, two strains of varicella-zoster virus, distinguishable by restriction endonuclease fragment size differences (wild-type strain EF and the OKA vaccine strain), were grown together in tissue culture. After three passages, the mixed infection virus was plaque-purified. DNA from about 13% of the plaque-purified isolates had one or more BglI fragments found in neither parental virus. Hybridization studies showed that isolates containing one of the new BglI fragments were recombinants of the two parental strains. The BglI restriction fragment pattern of these recombinants resembled those of the unusual varicella isolates from individuals either vaccinated with the live attenuated OKA varicella vaccine and later exposed to natural varicella, or simultaneously exposed to both a recent recipient of the vaccine and natural varicella.


Subject(s)
Herpesvirus 3, Human/genetics , Recombination, Genetic , Culture Techniques , DNA Restriction Enzymes , DNA, Viral/genetics , DNA, Viral/isolation & purification , Humans , Viral Vaccines/isolation & purification
10.
J Infect Dis ; 155(4): 633-40, 1987 Apr.
Article in English | MEDLINE | ID: mdl-3029239

ABSTRACT

Restriction endonuclease analysis of varicella-zoster virus (VZV) DNA has been used in unraveling the complex epidemiology of VZV infections in individuals immunized with a live, attenuated varicella virus vaccine. Early rashes appearing within the first six weeks after vaccination are invariably due to vaccine virus. True breakthrough infections with wild-type VZV also occur in vaccinees. Five cases of zoster have been seen in leukemic children vaccinated while in remission. One case appeared 22 months after vaccination in the same general area as the inoculation. The virus isolated was vaccine derived. A second case of zoster appeared in a dermatome unrelated to the sites of vaccination approximately 19 months after apparently natural varicella. This virus was wild type. Vaccine virus can therefore establish latency and can later reactivate as herpes zoster.


Subject(s)
Chickenpox/prevention & control , Herpesvirus 3, Human/immunology , Leukemia, Lymphoid/complications , Viral Vaccines , Adult , Chickenpox/etiology , Chickenpox Vaccine , Child , Child, Preschool , DNA Restriction Enzymes , DNA, Viral/analysis , Female , Herpes Zoster/etiology , Herpesvirus 3, Human/analysis , Humans , Male , Time Factors , Vaccination , Vaccines, Attenuated , Viral Vaccines/adverse effects
11.
J Virol ; 50(2): 615-8, 1984 May.
Article in English | MEDLINE | ID: mdl-6323760

ABSTRACT

Varicella-zoster virus DNA was digested with 11 restriction endonucleases, and the resulting fragments were separated on agarose gels. Terminal fragments were identified by lambda exonuclease digestion. Physical maps were then constructed using a combination of double restriction enzyme digestion and hybridization to cloned BamHI fragments to place the remaining fragments in order.


Subject(s)
DNA, Viral/genetics , Herpesvirus 3, Human/genetics , Base Sequence , Cells, Cultured , Cloning, Molecular , DNA Restriction Enzymes , Embryo, Mammalian , Female , Fibroblasts , Herpes Zoster/microbiology , Humans , Nucleic Acid Hybridization , Pregnancy
12.
J Med Virol ; 9(1): 69-76, 1982.
Article in English | MEDLINE | ID: mdl-6278073

ABSTRACT

The DNA from several clinical isolates of varicella-zoster virus (VZV) were compared with the DNA from the vaccine strain VZV using three restriction endonucleases: BamHI, BgII, and HpaI. When electrophoresed through an agarose gel, the vaccine DNA digestion pattern was significantly different from the digestion patterns of the wild-type DNAs. Variations in the digestion pattern of the separate clinical isolates were also observed.


Subject(s)
Bacterial Proteins , DNA Restriction Enzymes , Deoxyribonucleases, Type II Site-Specific , Capsid/isolation & purification , DNA Restriction Enzymes/pharmacology , DNA, Viral/analysis , Deoxyribonuclease BamHI , Electrophoresis, Agar Gel , Embryo, Mammalian , Fibroblasts , Herpesvirus 3, Human/genetics , Herpesvirus 3, Human/immunology , Humans , Viral Vaccines/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...